Read more: #DigitalTransformation #HealthTech #PredictiveAI #InnovationVista #FutureOfHealthcare To view or add a comment, sign in 11,781 followers More from this author Explore related topics Benefits of AI Innovations for Patients How AI Supports Chronic Disease Management How AI Influences Personal Health How AI Improves Patient Outcomes in Drug Discovery How AI Will Impact Cancer Therapy How Machine Learning Impacts Healthcare Limitations of AI in weight loss Impact of Glp-1 Medications on Health
Phase 2 trials showed up to 24.2% weight loss at 48 weeks, more than any other GLP-1 class medication tested so far
This side effect is usually mild and can often be managed by taking the injection with food or adjusting the timing of the dose
This means that even if the solution appears normal, it may not deliver the intended glucose-lowering or weight management effects
Ochratoxin A (OTA): Produced by Aspergillus and Penicillium species, OTA is nephrotoxic (kidney-damaging), immunosuppressive, and has been detected in human blood, breast milk, and urine